Abstract 499
Case Summary
Colonic perforation after stent placement is generally occurs in early phases, within 72 hours, whereas delayed perforations, which we define a perforation over 72 hours after stent placement, have been rarely described. A 76-year-old man, who had undergone stent placement for sigmoid colon obstruction 30 days before and discussed to undergo surgery at the outpatient care, presented sudden lower abdominal pain. He was diagnosed a lower gastrointestinal perforation and we planned to perform emergent surgery. In the operation, we recognized a large amount of stool odor ascites and a perforation from the sigmoid colon. We performed Hartmann procedure. At the gross findings of a specimen, the perforation was the junction areas between normal bowel wall and the tumor. He was discharged uneventfully at postoperative 29 day. Delayed colonic perforation after stent placement may be caused by the weakening of junction areas between normal bowel wall and the tumor or by tumor perforation due to mechanical tumor necrosis arising from stent and wire problems. Our case was the former. Delayed perforation is rare, but we cautiously take care of it long-term after stent placement
Editorial acknowledgement
Clinical trial identification
Resources from the same session
780 - The adipocyte suppresses the inhibitory role of hsa_circ_0000190 in the metastasis of breast cancer cells
Presenter: Xiu Chen
Session: Poster display - Cocktail
Resources:
Abstract
782 - CircASS1 suppressed the invasion and metastasis ability of breast cancer cell line by targeting gene ASS1 and harboring miR-4443
Presenter: Junchen Hou
Session: Poster display - Cocktail
Resources:
Abstract
916 - Ex-vivo drug sensitivity of primary breast cancer stems cell populations to potentiate therapeutic strategy for treatment resistant breast cancer
Presenter: Sourav Nandi
Session: Poster display - Cocktail
Resources:
Abstract
928 - Molecular Tumor Board (MTB): development of clinical pathways for precision medicine. Experiences of Center for Breast cancer at National cancer center, Korea
Presenter: In Hae Park
Session: Poster display - Cocktail
Resources:
Abstract
1274 - MicroRNA based immune response signature identifies poor prognostic subgroup within ER negative breast cancers
Presenter: Savitha Rajarajan
Session: Poster display - Cocktail
Resources:
Abstract
165 - The clinical efficacy of apatinib combined with Xeloda in advanced triple negative breast cancer
Presenter: YiHui Li
Session: Poster display - Cocktail
Resources:
Abstract
561 - Quality of life and psychosocial needs of metastatic breast cancer patients
Presenter: Tahir Mehmood
Session: Poster display - Cocktail
Resources:
Abstract
697 - TC-1 mediate the TBC1D3 oncogene induced migration of MCF-7 breast cancer cells
Presenter: Yong Shen
Session: Poster display - Cocktail
Resources:
Abstract
784 - RelB facilitates cell migration and invasion in breast cancer via MMP1 upregulation
Presenter: Mei Wang
Session: Poster display - Cocktail
Resources:
Abstract
921 - Re-challenging eribulin in patients with ER+HER2- metastatic breast cancer: A single-institution experience
Presenter: Junichiro Watanabe
Session: Poster display - Cocktail
Resources:
Abstract